{
  "cik": 1819133,
  "cik_padded": "0001819133",
  "entityName": "Tango Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-092518",
      "filed": "2026-03-05",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1048000.0,
        "cash": 112279000.0,
        "eps_diluted": -0.87,
        "free_cash_flow": -139934000.0,
        "net_income": -101594000.0,
        "operating_cash_flow": -138886000.0,
        "operating_income": -111289000.0,
        "revenue": 62384000.0,
        "stockholders_equity": 346179000.0,
        "total_assets": 398690000.0,
        "total_liabilities": 52511000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.15168742182512515,
        "revenue_growth_yoy": 0.48289714516627447,
        "roa_avg2y": -0.28410670290918955,
        "roa_period_end": -0.25481953397376406,
        "roe_avg2y": -0.372346507945816,
        "roe_period_end": -0.2934724521129242
      }
    },
    {
      "accn": "0001193125-26-092518",
      "filed": "2026-03-05",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 754000.0,
        "cash": 69530000.0,
        "eps_diluted": -1.19,
        "free_cash_flow": -132255000.0,
        "net_income": -130302000.0,
        "operating_cash_flow": -131501000.0,
        "operating_income": -145595000.0,
        "revenue": 42069000.0,
        "stockholders_equity": 199517000.0,
        "total_assets": 316492000.0,
        "total_liabilities": 116975000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.5862908925054006,
        "revenue_growth_yoy": 0.15172338270320584,
        "roa_avg2y": -0.36242366759890354,
        "roa_period_end": -0.4117070889627542,
        "roe_avg2y": -0.575761391880696,
        "roe_period_end": -0.6530872056015277
      }
    },
    {
      "accn": "0001193125-26-092518",
      "filed": "2026-03-05",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1526000.0,
        "cash": 66385000.0,
        "eps_diluted": -1.08,
        "free_cash_flow": -119508000.0,
        "net_income": -101744000.0,
        "operating_cash_flow": -117982000.0,
        "operating_income": -114173000.0,
        "revenue": 36527000.0,
        "stockholders_equity": 253108000.0,
        "total_assets": 402567000.0,
        "total_liabilities": 149459000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.590494966575533,
        "revenue_growth_yoy": 0.46930812550281575,
        "roa_avg2y": -0.24252565739055607,
        "roa_period_end": -0.25273805354139806,
        "roe_avg2y": -0.4048835617528612,
        "roe_period_end": -0.4019786020196912
      }
    },
    {
      "accn": "0001193125-26-092518",
      "filed": "2026-03-05",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7692000.0,
        "cash": 59968000.0,
        "eps_diluted": -1.23,
        "free_cash_flow": -116772000.0,
        "net_income": -108176000.0,
        "operating_cash_flow": -109080000.0,
        "operating_income": -111071000.0,
        "revenue": 24860000.0,
        "stockholders_equity": 249476000.0,
        "total_assets": 436470000.0,
        "total_liabilities": 186994000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7495470506180956,
        "revenue_growth_yoy": -0.32886993142918847,
        "roa_avg2y": -0.2309910583210997,
        "roa_period_end": -0.24784292162118818,
        "roe_avg2y": -0.364092268390823,
        "roe_period_end": -0.43361285253892157
      }
    },
    {
      "accn": "0000950170-25-028353",
      "filed": "2025-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1837000.0,
        "cash": 142745000.0,
        "eps_diluted": -0.94,
        "free_cash_flow": -61364000.0,
        "net_income": -58235000.0,
        "operating_cash_flow": -59527000.0,
        "operating_income": -58190000.0,
        "revenue": 37042000.0,
        "stockholders_equity": 344747000.0,
        "total_assets": 500155000.0,
        "total_liabilities": 155408000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.45078854928396767,
        "revenue_growth_yoy": 3.838296760710554,
        "roa_avg2y": -0.16464355031827504,
        "roa_period_end": -0.11643390548929831,
        "roe_avg2y": -0.30382395062436907,
        "roe_period_end": -0.1689209768322857
      }
    },
    {
      "accn": "0000950170-23-009854",
      "filed": "2023-03-27",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1106000.0,
        "cash": 28381000.0,
        "free_cash_flow": 68968000.0,
        "net_income": -51972000.0,
        "operating_cash_flow": 70074000.0,
        "operating_income": -52200000.0,
        "revenue": 7656000.0,
        "stockholders_equity": 38600000.0,
        "total_assets": 207252000.0,
        "total_liabilities": 168652000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 4.369222797927461,
        "roa_period_end": -0.25076718198135606,
        "roe_avg2y": -2.235114503816794,
        "roe_period_end": -1.3464248704663213
      }
    },
    {
      "accn": "0000950170-22-004721",
      "filed": "2022-03-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 7905000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-092518",
    "filed": "2026-03-05",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001819133.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001819133.json"
  },
  "ticker": "TNGX"
}